Tulathromycin Veterinary Raw Material Tulathromycin Powder CAS 217500-96-4

• Function: Vitamins and Minerals Deficiency Drug
• Grade Standard: Medicine Grade
• Type: Chemical Reagent
• State: Powder
• Volatile: Not Volatile
• Standard: USP
• Model NO.: py0088
• MOQ: 1kg
• Package: Carton
• Shipping: FedEx
• Transport Package: 25kg/Drum
• Specification: 99%
• Trademark: puya
• Origin: China
• Production Capacity: 20ton/Year

Product Description

Tulathromycin Powder  cas 217500-96-4

Product Name	Tulathromycin
CAS	217500-96-4
Appearance	White crystalline powder
MF	C41H79N3O12
MW	806.08
Purity	99%
Shelf Life	2 Years

Tulathromycin is mainly used for the respiratory diseases of pigs and cattle caused by actinobacillus, mycoplasma, pasteurella and haemophilus parahaemophilus.
It has many advantages, such as low dosage, single dose, low residue and special for animals.


Function
•   Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs.

•   Clinical effectiveness of tulathromycin 217500-96-4, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease.

    The efficacy of tulathromycin 217500-96-4 in decreasing the incidence of morbidity and mortality due to bovine respiratory disease (BRD) in 1,239 high-risk cattle was investigated at four US feedlots. Calves not exhibiting clinical signs of BRD received one of three treatments administered subcutaneously in the neck: physiologic saline at 0.02 ml/kg, tulathromycin 217500-96-4 at 2.5 mg/kg, or tilmicosin at 10 mg/kg. Each treatment group consisted of 413 calves. Calves with clinical signs of BRD and rectal temperatures of 104 degrees F or higher on days 1 through 14 were considered treatment failures (BRD morbidity). Nasopharyngeal swabs from saline-treated morbidities were submitted for isolation and identification of BRD organisms. Respiratory disease morbidity was highest in calves treated with saline and significantly (P < or = .0001) lower in calves administered tulathromycin 217500-96-4 or tilmicosin. Morbidity from BRD was significantly (P < or = .0001) higher in calves treated with tilmicosin than in calves treated with tulathromycin 217500-96-4. Under conditions of this study, tulathromycin 217500-96-4, given to calves at high risk of developing BRD, was significantly more effective in reducing BRD morbidity when compared to both saline- and tilmicosin-treated calves.

Related product

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
Albendazole	54965-21-8	Mebendazole	31431-39-7